Trial Profile
Phase II/III trial of fruquintinib in patients with solid tumours
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 15 Oct 2013
Price :
$35
*
At a glance
- Drugs Fruquintinib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Hutchison MediPharma
- 15 Oct 2013 New trial record